Estonia – Laboratory reagents – Diagnostikumid ning interpreteerimise tarkvarad HLA tüpiseerimiseks reaal-aja PCR ning NGS meetodil
Opportunity Score
Confidence: 40%
Complexity: medium
31 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by Tartu University Hospital (Sihtasutus Tartu Ülikooli Kliinikum) seeks to establish a framework agreement for the supply of diagnostics and interpretation software for HLA typing using real-time PCR and NGS methods. The agreement is for 24 months and covers one lot. The procedure is open and electronic submission is required. The notice is in Estonian, and no estimated value is provided. Procurement documents are available but were not analyzed.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Ability to perform HLA typing for 11 specified loci simultaneously.
- Submission must be in Estonian.
- Electronic submission is required.
Buyer
Name
sihtasutus Tartu Ülikooli Kliinikum
Location
Tartu linn, EST
Website
Buyer profile
Identifier
90001478
Lots (1)
Framework agreement for diagnostics and interpretation software licenses for HLA typing at low and high resolution for 11 loci (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DBR5, HLA-DQA1, HLA-DQB1, HLA-DPA1, HLA-DPB1) using real-time PCR and NGS methods over 24 months.
Procurement Details
Publication
14 Jun 2026
Deadline
16 Jul 2026, 08:00
Procedure
open
Contract
supplies
Duration
24 MONTH
Language
EST
Publication #
406532-2026
Classification
Performance: Estonia
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: medium
31 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation